On Friday, the company’s health services unit Evernorth unveiled new programs in a reliable growth area: helping payers ...

and Lilly’s Zepbound (tirzepatide). According to the group’s soon-to-depart chief scientific officer, Mikael Dolsten, Pfizer has a “robust pipeline” of three clinical and several ...